A project from the American Society of Retina SpecialistsSign in to view content
Avacincaptad Pegol, A Novel C5 Inhibitor, Reached Statistical Significance in a Pivotal Clinical Trial for Geographic Atrophy Secondary to Dry AMD
- Video
- Published 2020
Related
Category: AMD-Neovascular